Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Polaris GroupTPE:6550 +2.40%59 PB Ratio is 2.08 as of Jul. 16, 2026, which is 71% below its 10-year median of 7.07. GuruFocus rates TPE:6550 with a GF Score™ of 59/100 and a GF Value™ of NT$55.56 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,227 Biotechnology companies, Polaris Group ranks better than 63.08% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-16), Polaris Group's share price is NT$12.80. Polaris Group's Book Value per Share for the quarter that ended in Dec. 2025 was NT$6.16. Hence, Polaris Group's PB Ratio of today is 2.08.
Good Sign:
Polaris Group stock PB Ratio (=2.11) is close to 10-year low of 2.03.
The historical rank and industry rank for Polaris Group's PB Ratio or its related term are showing as below:
TPE:6550'
s PB Ratio Range Over the Past 10 Years
Min: 1.99 Med: 7.07 Max: 20.95
Current: 2.08
During the past 12 years, Polaris Group's highest PB Ratio was 20.95. The lowest was 1.99. And the median was 7.07.
TPE:6550's PB Ratio is ranked better than 63.08% of 1227
companies
in the Biotechnology industry
Industry Median: 2.93
vs TPE:6550: 2.08
During the past 12 months, Polaris Group's average Book Value Per Share Growth Rate was -29.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -19.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 3.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 17.30% per year.
During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Polaris Group was 82.20% per year. The lowest was -23.30% per year. And the median was 18.30% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Polaris Group PB Ratio Related Terms
Polaris Group PB Ratio Historical Data
* Premium members only.
The historical data trend for Polaris Group's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Polaris Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polaris Group PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Polaris Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where Polaris Group's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Polaris Group's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Polaris Group (TPE:6550) has a PB Ratio of 2.08 as of Jul. 16, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Polaris Group and its competitors. This is 71% below median its historical median of 7.07. Over the past decade, Polaris Group's PB Ratio has ranged from 1.99 to 20.95. According to the industry distribution chart, Polaris Group ranks #453 out of 1227 companies in the Biotechnology industry, placing it in the top 36.9%.
Is Polaris Group's PB Ratio too high?
Polaris Group's current PB Ratio of 2.08 is 71% below median its 10-year median of 7.07. Over the past 10 years, this metric has ranged from a low of 1.99 to a high of 20.95. The Biotechnology industry median PB Ratio is 2.93. Polaris Group's value of 2.08 is 29% below this industry median. Based on the distribution chart, Polaris Group ranks #453 out of 1227 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Polaris Group has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Polaris Group's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Polaris Group ranks #453 out of 1227 companies for PB Ratio. This puts Polaris Group in the upper half of its industry. The industry median PB Ratio is 2.93. Polaris Group's value of 2.08 is 29% below this benchmark. Historically, Polaris Group's own PB Ratio has ranged from 1.99 to 20.95 over the past decade. While the company's 10-year median is 7.07 vs. the industry median of 2.93, Polaris Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.93, based on 1,227 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Polaris Group's current PB Ratio of 2.08 is 29% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Polaris Group and its competitors. For the Biotechnology industry, the median PB Ratio is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polaris Group's current PB Ratio is 2.08, which is 71% below median its own 10-year median of 7.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polaris Group stock overvalued right now?
Based on GuruFocus' analysis, Polaris Group (TPE:6550) is currently considered Possible Value Trap. The stock's GF Value™ is NT$55.56, compared to a current price of NT$12.80 — trading 77% below its estimated fair value. The current PB Ratio is 2.08, which is 71% below median its 10-year median of 7.07 and 29% below the Biotechnology industry median of 2.93. Polaris Group's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Polaris Group (TPE:6550), the current PB Ratio is 2.08 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Polaris Group (TPE:6550) Overvalued in 2026?
Based on GuruFocus' analysis, Polaris Group stock appears to be undervalued.
The current stock price of NT$12.80 is trading 77% below its estimated GF Value™ of NT$55.56.
GuruFocus considers Polaris Group to be Possible Value Trap.
Key valuation signals for TPE:6550:
PB Ratio: 2.08 (71% below median its 10-year median of 7.07)
GF Value™: NT$55.56 vs. price of NT$12.80 (77% below fair value)
Industry Position: 29% below the Biotechnology median (#453 of 1227)
No single metric tells the full story. See the TPE:6550 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Polaris Group is a multinational biotechnology company focused on developing novel anti-cancer therapies. The company's lead therapeutic Pegargiminase (ADI PEG 20), is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Polaris Group is also involved in every stage of the drug development process.
59GF Score
Get the complete analysis for TPE:6550
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6550 has been successfully added to your 
